Only EU-based drugmaker in Trump's pricing deal keeps Europe guessing on cost

EURACTIV - UCB is the only company headquartered in the European Union among the nine drugmakers that signed Donald Trump's most-favoured-nation pricing plan on Monday, 31 August. Its new US factory will not come at Europe's expense, the Brussels-based company said. Read more

WASHINGTON, DC - AUGUST 31: Jean-Christophe Tellier, Chairman and CEO of UCB (2nd-R), joined by (L-R) Commerce Secretary Howard Lutnick, U.S. President Donald Trump, Health and Human Services Secretary Robert F. Kennedy Jr. and others. [Official White House Photo by Molly Riley]